2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$2.60+$0.04 (+1.72%)
Price as of Jun 23, 2026 7:27 PM EDT- $1.9MMarket Cap
- -97.36%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$2.60+$0.04 (+1.72%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.56 | ||
Change | +$0.36 (+16.00%) | ||
Open | $2.50 | ||
High | $2.64 | ||
Low | $2.46 | ||
Previous Close | $2.61 | ||
Volume | 103,108 | ||
30-Day Average Volume | 94,447 | ||
1-Week Change | 5.67% | ||
1-Month Change | -10.31% | ||
1-Year Change | -96.96% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 722,024 | ||
Total Assets | $37.4M | ||
Market Cap | $1.9M | ||
Enterprise Value | $27.8M | ||
Period: QTR TTM FY | |||
Revenue | $19.0M | ||
Net Income | $8.7M | ||
Free Cash Flow | $8.8M | ||
EBIT | $9.4M | ||
EBITDA | $9.9M | ||
Net Working Capital | -$20.5M | ||
EPS | -$476.00 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 1 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | 0 | ||
Price/Operating Cash Flow | 0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/30/2026 | ||
Earnings & Revenue